Intensity Therapeutics surges 395% on phase 1/2 data for solid tumors asset
Intensity Therapeutics (INTS), with a ~$13M market cap, closed up nearly 395% Thursday after publishing phase ...
Tag: Intensity
Intensity Therapeutics (INTS), with a ~$13M market cap, closed up nearly 395% Thursday after publishing phase ...